|
Jul 28
|
Alpha-synuclein Inhibitors Market to Witness Strong CAGR Through 2034, Driven by Advances in Neurodegenerative Therapies | DelveInsight
|
|
Jul 21
|
Bipolar Disorder Market Research Report 2025-2035 | Pharma Leaders Advance Bipolar Disorder Treatment with Targeted Therapies and Genomic Innovation
|
|
Oct 14
|
Lundbeck to acquire Longboard Pharmaceuticals in $2.6B deal
|